EVADE Site Registration Open

EVADE (Evaluating Variation in management following admission with Acute DEcompensation of cirrhosis) is a trainee-led national multicentre audit, and our first study with a prospective design! It is led by ToRcH-UK (national research network for trainees and AHPs), supported by a Guts UK grant and we are grateful for wide endorsement from BASL, BSG, SSG, WAGE, USG, and the British Liver Trust.

Following acute decompensation (AD) of cirrhosis, patients experience significant morbidity with 90-day mortality rates greater than 50% for the sickest patients. Significant variation in care exists and the BSG/BASL Decompensated Cirrhosis Discharge Bundle was developed to try and improve and standardise care. The aim of this study is to evaluate management and outcomes after discharge against these standards, looking at regional variation, and re-admission and mortality at 30, 60 and 90 days. From speaking to patients, we know this is an important area of unmet need!

If you would like to take part, please access the EVADE study dashboard which provides the protocol and supporting materials. A collaborative authorship model on future publications will be employed for all contributors. If you have any questions, please contact us via committee@torchuk.org.

‍